Position in GILD
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$614,012
-$21,933 QoQ
Shares Held
4,860
+6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,287
of 2,266 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Western Financial Corp/CA holds $8,064,519 across 7 Drug Manufacturers - General names. GILD ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,819 | $4,779,461 | |
| 2 | MRK |
Merck & Co., Inc.
|
5,469 | $702,766 | |
| 3 | AMGN |
Amgen Inc
|
1,902 | $688,752 | |
| 4 | LLY |
ELI LILLY & Co
|
513 | $615,307 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
4,860 | $614,012 | |
| 6 | PFE |
Pfizer Inc
|
14,678 | $353,446 | |
| 7 | ABBV |
AbbVie Inc.
|
1,235 | $310,775 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $614,012 | 4,860 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $635,945 | 4,563 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $484,454 | 3,947 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $450,438 | 4,058 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $516,099 | 4,655 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,109,519 | 9,902 | Shares | Sole | 2025-04-23 | |
| 2023-06-30 | $474,905 | 6,162 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $445,382 | 5,368 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $336,360 | 3,918 | Shares | Sole | 2023-01-20 | |
| No filing history on record for this holder in this stock. | ||||||